Prudential Financial’s Damora Therapeutics DMRA Stock Holding History

Prudential Financial’s Portfolio DMRA Stock Details DMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$228K	Buy	+8,755	New	+$212K	﹤0.01%	2191

Other funds holding DMRA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Jupiter Topco New York $245B AUM

RCP

Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Prudential Financial's DMRA Position: Q2 2026 in Review

Prudential Financial opened a new position in Damora Therapeutics (DMRA) in Q2 2026: 8,755 shares worth $228K. The stake represents ﹤0.01% of the portfolio and ranks #2191 among its holdings.

104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

Prudential Financial held 8,755 shares of Damora Therapeutics worth $228K as of Q2 2026.
Damora Therapeutics was a new Prudential Financial position in Q2 2026.
Damora Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2191 holding.
104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.